DexCom Inc (DXCM)

Debt-to-equity ratio

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Long-term debt	US$ in thousands	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total stockholders’ equity	US$ in thousands	2,102,600	1,979,000	2,434,300	2,246,800	2,068,600	2,267,900	2,100,400	2,233,000	2,131,800	1,824,500	2,255,900	2,189,300	2,251,500	2,136,100	1,997,600	1,903,200	1,826,500	1,499,300	1,353,900	934,500
Debt-to-equity ratio		0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

December 31, 2024 calculation

Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $2,102,600K
= 0.00

Based on the provided data, DexCom Inc has consistently maintained a debt-to-equity ratio of 0.00 across all reported periods from March 31, 2020, to December 31, 2024. A debt-to-equity ratio of 0.00 indicates that the company has no financial leverage through debt and is solely financed by equity. This suggests that DexCom Inc has a strong financial position with no significant debt obligations relative to its equity.

A debt-to-equity ratio of 0.00 may be viewed positively by investors and creditors as it signifies a low risk of financial distress due to debt repayment obligations. However, it is important to note that a very low or zero debt-to-equity ratio may also indicate underutilization of debt as a financing source, which could potentially limit the company's growth opportunities or tax advantages associated with debt financing.